Template:Side effects of combined androgen blockade with nilutamide and a GnRH agonist

v
t
e
Side effects of combined androgen blockade with nilutamide and a GnRH agonist
Class	Side effect	Nilutamide 150 mg/day + leuprorelin (n = 209) (%)^a,b	Placebo + leupro- relin (n = 202) (%)^a,b
Body as a whole	Pain	26.8	27.7
	Headache	13.9	10.4
	Asthenia	19.1	20.8
	Back pain	11.5	16.8
	Abdominal pain	10.0	5.4
	Chest pain	7.2	4.5
	Flu syndrome	7.2	3.0
	Fever	5.3	6.4
Cardiovascular system	Hypertension	9.1	9.9
Digestive system	Nausea	23.9	8.4
	Constipation	19.6	16.8
	Anorexia	11.0	6.4
	Dyspepsia	6.7	4.5
	Vomiting	5.7	4.0
Endocrine system	Hot flashes	66.5	59.4
	Erectile dysfunction	11.0	12.9
	Decreased libido	11.0	4.5
Hemic and lymphatic system	Anemia	7.2	6.4
Metabolic and nutritional system	Increased aspartate transaminase	12.9	13.9
	Peripheral edema	12.4	17.3
	Increased alanine transaminase	9.1	8.9
Musculoskeletal system	Bone pain	6.2	5.0
Nervous system	Insomnia	16.3	15.8
	Dizziness	10.0	11.4
	Depression	8.6	7.4
	Hypesthesia	5.3	2.0
Respiratory system	Dyspnea	10.5	7.4
	Upper respiratory infection	8.1	10.9
	Pneumonia	5.3	3.5
Skin and appendages	Sweating	6.2	3.0
	Decreased body hair	5.7	0.5
	Dry skin	5.3	2.5
	Rash	5.3	4.0
Special senses	Impaired adaptation to darkness	56.9	5.4
	Chromatopsia	8.6	0.0
	Impaired adaptation to light	7.7	1.0
	Abnormal vision	6.2	4.5
Urogenital system	Testicular atrophy	16.3	12.4
	Gynecomastia	10.5	11.9
	Urinary tract infection	8.6	21.3
	Hematuria	8.1	7.9
	Urinary tract disorder	7.2	10.4
	Nocturia	6.7	6.4
Overall		99.5	98.5
Footnotes: ^a = Phase III studies of combined androgen blockade (nilutamide + GnRH agonist) in men with advanced prostate cancer. ^b = Incidence ≥5% regardless of causality. Sources: ^[1]

Usage